Fund managers are buying Kogan (ASX:KGN) and this ASX share

Fund managers have been loading up on these ASX shares…

I like to keep an eye on substantial shareholder notices. This is because these notices give you an idea of which shares large investors, asset managers, and investment funds are buying or selling.

Two notices that have caught my eye are summarised below. Here's what this fund manager has been buying:

Image of fund managers on laptops with share price chart overlaid

Image source: Getty Images

Kogan.com Ltd (ASX: KGN)

According to a change of interests of substantial holder notice, UK based Hosking Partners has taken advantage of recent weakness in the Kogan share price to increase its stake in the online retailer. The notice reveals that the fund manager has lifted its stake to ~6.51 million shares, which is the equivalent of a 6.09% stake.

Hosking Partners' most recent purchase came on 3 September when it picked up 315,553 Kogan shares for just under $3.5 million. This represents an average of $11.00 per share. Since then, the Kogan share price has pulled back to $10.50, giving investors an opportunity to buy at a decent discount to what this fund manager paid.

Credit Suisse appears to believe this is a buying opportunity. Late last month it put an outperform rating and $14.06 price target on Kogan's shares.

Universal Store Holdings Ltd (ASX: UNI)

According to a notice of initial substantial holder, WAM Capital Limited (ASX: WAM) has become a substantial shareholder of this fashion retailer. The notice reveals that WAM and its affiliates now own a total of 3,852,539 shares. This gives the fund manager an interest of 5.26%.

WAM was buying shares as recently as earlier this week. On 7 September, it picked up 250,000 Universal Store shares for a total consideration of $1.82 million. This equates to an average of $7.31 per Universal Store share.

The good news for WAM is that one leading broker still sees plenty of upside for the Universal Store share price. Last month Macquarie put an outperform rating and $8.90 price target on the company's shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Kogan.com ltd. The Motley Fool Australia owns shares of and has recommended Kogan.com ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a remarkably positive end to the trading week.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

One large yellow sphere on one side of a white seesaw, with a small yellow sphere on the other side.
Opinions

I investigated 3 ASX shares that have fallen sharply. Are they bargains or value traps?

I've given my verdict on three depressed high-profile stocks.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Opinions

These are the best 3 ASX growth shares I own and I'd buy more of today

I’m bullish about the earnings potential of these three ASX growth shares.

Read more »